Trial intelligence / Profile preview

CaZa study of zanubrutinib in primary cold agglutinin disease

NL-OMON58968Phase 2Active, not recruiting

Sponsor

HOVON

Start

Jul 2024

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1